Iron Deficiency and/or AnemiaMM_RiceNCT02714075
Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Zinc, Citric Acid/Trisodium Citrate and EDTA
A study testing Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate in people with Iron Deficiency and/or Anemia, run by Swiss Federal Institute of Technology at 2 sites in 2 countries.
Trial summary
Rice can only be fortified with ferric pyrophosphate (FePP), which is of low bioavailability in human subjects. Compounds such as citric acid/trisodium citrate (CA/TSC) or sodium ethylene-diamine tetraacetic-acid (EDTA) could serve as absorption enhancers. Read more about this study
- Who is it for?
- Ages 5 to 9 years
- Conditions the study is for
- Iron Deficiency and/or Anemia
- What is being tested?
- Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 2 sitesin 2 countries
- Study dates
- Apr 2016to Jun 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 9 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Iron deficient and/or anemic as per definition;
- Read and signed informed consent form by the caregiver (or has been read out to the caregiver in case of illiteracy);
- Absence of any metabolic-, gastrointestinal or chronic diseases.
Who cannot join
- Severe underweight (Z-score weight-for-age <-3);
- Severe wasting (Z-score weight-for-height<-3);
- Chronic or acute illness or other conditions that in the opinion of the Principle Investigator (PI) or co-researchers would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol;
- Participants taking part in other studies requiring the drawing of blood;
- Participants who will not be able to comply with the protocol (e.g. plan to move, planned absence, etc.);
- Regular intake (>2 days) of iron-containing mineral and vitamin supplements within the last 2 months.
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Switzerland1 site
Swiss Federal Institute of Technology (ETH)
Zurich, Canton of Zurich, 8092
About this study
Official title: Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Different Zinc Compounds, Citric Acid/Trisodium Citrate and Sodium EDTA
Rice can only be fortified with ferric pyrophosphate (FePP), which is of low bioavailability in human subjects. Compounds such as citric acid/trisodium citrate (CA/TSC) or sodium ethylene-diamine tetraacetic-acid (EDTA) could serve as absorption enhancers. Recent findings from single meal studies indicate CA/TSC to have an enhancing effect on iron absorption from FePP-fortified rice. In contrast, ZnO has been suggested to have detrimental effects. Furthermore, in vitro findings suggest an increased iron solubility from iron and EDTA-co-fortified rice - but the bioavailability in humans remains to be investigated. These effects should thus be investigated in 'real-life' conditions, when fortified rice is implemented in a complete diet administered throughout several days in a target population for a rice fortification program.
Objective: To assess iron absorption from the diet from different iron fortified rice formulations in iron deficient anaemic children.
The investigators aim to conduct an iron absorption study in 30 Ghanaian school-age children investigating different fortification approaches in a multiple meal randomized, cross over study.
Read the detailed description
Iron of differing molecular weights (54Fe, 56Fe, 57Fe, 58Fe) and other nutrients and additives will be extruded into rice kernels, these kernels will be blended with regular unfortified rice and administered to the study participants.
Recruitment of study participants will be through a local investigator in close collaboration with the Ghanaian school authorities. Before starting the study, 6 children will be asked to participate in a pilot testing, where they will be administered 2 portions of rice (50 g dry weight) with a vegetable sauce with a four hours delay in between the meals. This is to allow the investigators to define, the optimal portion size, that will be used throughout the study. For their participation, the children will receive a small symbolic gift. The investigators envisage screening approximately 60 children living in Tamale and surrounding rural areas at least one week before study start. Recruitment of participants will be done until reaching a number of 30 eligible participants. Participant's caretakers will be explained the study procedures and need to sign a consent form before the participant is exposed to any study procedure. Participants at screening will be assigned a unique study identification (running number and participant's initials), which they will keep if included in the study. All data will be kept confidential. The medical history, dietary intake data and data concerning socioeconomic status will be assessed using questionnaires, body temperature, height and weight will be measured and z-scores (weight for age) will be calculated. A blood sample will be collected from each participant for the initial determination of iron status, detection of parasitic infections (including measurements of hemoglobin (Hb), serum ferritin (SF), soluble transferrin receptor (sTfR), Zinc protoporphyrin to heme ratio (ZPP), C-reactive protein (CRP), Alpha acid glycoprotein, and malaria parasitemia. All screened participants will receive an appropriate dose of an anthelmintic free of charge, unless they had received an according treatment within the last two months. Based on the information obtained from screening, in-/ exclusion criteria will be checked and participant's eligibility will be judged accordingly. Thirty iron deficient and/or anemic children (hereafter called participants) will be included in the absorption study. For the initial determination of the iron status and infection detection, the children will receive a symbolic gift from the investigators. There will be no monetary compensation for participation; however, the children or their caregivers will receive a symbolic gift for completion of the study. Potential transport costs for the children and their caregivers will be covered by the project.
The whole study duration will be eleven weeks (excluding screening and pilot testing). Participants will donate one blood sample at screening and two blood samples during the remaining study period. Between Monday and Friday, the participants will receive two meals per day, one in the morning (first meal) and one at noon (second meal). One type of test meal will always be administered throughout five consecutive days. In total each participant will receive 60 rice meals each meal consisting of approximately 50 g regular unfortified rice, 0.5 g extruded fortified rice, 30 g sauce and 250 ml water. The definite rice amount administered will be decided upon after a pilot investigation. The order of the test meals given in each week will be partially randomized. Thus, if test meals A, B or C will be given throughout 1 week between weeks 1 and 3, test meals D, E and R will be given between weeks 6 and 8. Meals containing iron with the same molecular weight (58 Fe, 57Fe and 54Fe) have to be administered at least 16 days apart from each other, which is the only restriction for randomization. The participants are not allowed to eat after 8 PM and to drink after 12 AM on the day before each study visit, between the meals and for three hours after they finished their second meal, unless they are given snacks by the investigators and are explicitly allowed to eat those. Each meal administration will take approximately 25 minutes. This procedure will be followed for six weeks, with a two weeks break between weeks 3 and 6 (no dietary restrictions within the break-period).
The test meals will be based on 50 g regular unfortified rice and 0.5 g extruded fortified rice (dry weight). The meals will be administered with one of two traditional sauces, with a low (sauce A) or moderate (sauce B) phytic acid (PA) content. Sauce A will be based on tomatoes and onions, sauce B will be based on cowpeas. The rice meals will be prepared individually for each subject, the sauce will be prepared in bulk before the study start. All meals will be served with 250 ml water. The test meals are designed to match ~2/3 of the average dietary requirements in that age-group. In case the rice meals do not provide enough energy (~700 - 900 kcal), the investigators will administer a standardized snack to be consumed during the fasting periods.
- Conditions
- Iron Deficiency and/or Anemia
- Being tested
- Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate, Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate, Ferric Pyrophosphate, ZnSO4, CA/TSC, Ferric Pyrophosphate, ZnO, CA, EDTA
- Medical subject headings
- Anemia, Iron-Deficiency
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ferric Pyrophosphate and Zinc OxideOther
Extruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO) and micronutrients
Ferric Pyrophosphate and Zinc SulphateOther
Extruded rice fortified with Ferric Pyrophosphate, Zinc Sulphate (ZnSO4) and micronutrients
Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium CitrateOther
Extruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO), Citric Acid (CA) and Trisodium Citrate (TSC) and micronutrients
Ferric Pyrophosphate, ZnSO4, CA/TSCOther
Extruded rice fortified with Ferric Pyrophosphate, ZnSO4, CA/TSC and micronutrients
Ferric Pyrophosphate, ZnO, CA, EDTAOther
Extruded rice fortified with Ferric Pyrophosphate, ZnO, CA, EDTA and micronutrients
Ferrous SulphateOther
Extruded rice fortified with micronutrients, Ferrous Sulphate solution will be added at consumption
| Study group | Role | What they receive |
|---|---|---|
| Iron fortified rice | Experimental | Administration of iron fortified rice to all subjects; subjects will act as their own controls and each subject will receive all foreseen treatments/interventions. Receives: Other: Ferric Pyrophosphate and Zinc Oxide; Other: Ferric Pyrophosphate and Zinc Sulphate; Other: Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate; Other: Ferric Pyrophosphate, ZnSO4, CA/TSC; Other: Ferric Pyrophosphate, ZnO, CA, EDTA; Other: Ferrous Sulphate |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fractional iron absorption
Change from baseline in the isotopic ratio of iron in blood at week 6 and 11after the administration of test meal including iron isotopes.
Measured: baseline, 6 weeks, 11 weeks
Secondary outcomes (6)
Hemoglobin
Measurements from blood will be given in mg/l.
Measured: Baseline, Week 6, Week 11
Plasma Ferritin
Measurements from blood will be given in mg/l.
Measured: Baseline, Week 6, Week 11
C-reactive protein
Measurements from blood will be given in mg/l.
Measured: Baseline, Week 6, Week 11
Zinc protoporphyrin measurement as zinc to heme ratio
Measured: Baseline, Week 6, Week 11
Soluble Transferrin receptor in mg/l
Measured: Baseline, Week 6, Week 11
Alpha amino glycoprotein in mg/l
Measured: Baseline, Week 6, Week 11
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2016 (estimated)
- Study startApr 2016
- Primary completionJun 2016
- Study completionJun 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Iron Deficiency and/or AnemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Swiss Federal Institute of Technology
- Sponsor type
- University, hospital or other
- Collaborators
- University for Development Studies, Tamale, Ghana
- Responsible party
- Sponsor
- Investigators
- Michael B Zimmermann, Prof. Dr., Principal investigator, Swiss FIT
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02714075
- Sponsor's protocol ID
- MM_Rice
- Acronym
- MM_Rice
- Status last verified
- Dec 2016
- First submitted
- 10 Mar 2016
- Last updated
- 7 Dec 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Dec 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Different Zinc Compounds, Citric Acid/Trisodium Citrate and Sodium EDTA
- ClinicalTrials.gov ID
- NCT02714075
- Acronym / sponsor ID
- MM_Rice / MM_Rice
- Conditions
- Iron Deficiency and/or Anemia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Swiss Federal Institute of TechnologyUniversity, hospital or other
- Collaborators
- University for Development Studies, Tamale, Ghana
- Study start
- Apr 2016
- Primary completion
- Jun 2016 (actual)
- Study completion
- Jun 2016 (actual)
- First posted
- 21 Mar 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Rice can only be fortified with ferric pyrophosphate (FePP), which is of low bioavailability in human subjects. Compounds such as citric acid/trisodium citrate (CA/TSC) or sodium ethylene-diamine tetraacetic-acid (EDTA) could serve as absorption enhancers. Recent findings from single meal studies indicate CA/TSC to have an enhancing effect on iron absorption from FePP-fortified rice. In contrast, ZnO has been suggested to have detrimental effects. Furthermore, in vitro findings suggest an increased iron solubility from iron and EDTA-co-fortified rice - but the bioavailability in humans remains to be investigated. These effects should thus be investigated in 'real-life' conditions, when fortified rice is implemented in a complete diet administered throughout several days in a target population for a rice fortification program.
Objective: To assess iron absorption from the diet from different iron fortified rice formulations in iron deficient anaemic children.
The investigators aim to conduct an iron absorption study in 30 Ghanaian school-age children investigating different fortification approaches in a multiple meal randomized, cross over study.
Detailed description
Iron of differing molecular weights (54Fe, 56Fe, 57Fe, 58Fe) and other nutrients and additives will be extruded into rice kernels, these kernels will be blended with regular unfortified rice and administered to the study participants.
Recruitment of study participants will be through a local investigator in close collaboration with the Ghanaian school authorities. Before starting the study, 6 children will be asked to participate in a pilot testing, where they will be administered 2 portions of rice (50 g dry weight) with a vegetable sauce with a four hours delay in between the meals. This is to allow the investigators to define, the optimal portion size, that will be used throughout the study. For their participation, the children will receive a small symbolic gift. The investigators envisage screening approximately 60 children living in Tamale and surrounding rural areas at least one week before study start. Recruitment of participants will be done until reaching a number of 30 eligible participants. Participant's caretakers will be explained the study procedures and need to sign a consent form before the participant is exposed to any study procedure. Participants at screening will be assigned a unique study identification (running number and participant's initials), which they will keep if included in the study. All data will be kept confidential. The medical history, dietary intake data and data concerning socioeconomic status will be assessed using questionnaires, body temperature, height and weight will be measured and z-scores (weight for age) will be calculated. A blood sample will be collected from each participant for the initial determination of iron status, detection of parasitic infections (including measurements of hemoglobin (Hb), serum ferritin (SF), soluble transferrin receptor (sTfR), Zinc protoporphyrin to heme ratio (ZPP), C-reactive protein (CRP), Alpha acid glycoprotein, and malaria parasitemia. All screened participants will receive an appropriate dose of an anthelmintic free of charge, unless they had received an according treatment within the last two months. Based on the information obtained from screening, in-/ exclusion criteria will be checked and participant's eligibility will be judged accordingly. Thirty iron deficient and/or anemic children (hereafter called participants) will be included in the absorption study. For the initial determination of the iron status and infection detection, the children will receive a symbolic gift from the investigators. There will be no monetary compensation for participation; however, the children or their caregivers will receive a symbolic gift for completion of the study. Potential transport costs for the children and their caregivers will be covered by the project.
The whole study duration will be eleven weeks (excluding screening and pilot testing). Participants will donate one blood sample at screening and two blood samples during the remaining study period. Between Monday and Friday, the participants will receive two meals per day, one in the morning (first meal) and one at noon (second meal). One type of test meal will always be administered throughout five consecutive days. In total each participant will receive 60 rice meals each meal consisting of approximately 50 g regular unfortified rice, 0.5 g extruded fortified rice, 30 g sauce and 250 ml water. The definite rice amount administered will be decided upon after a pilot investigation. The order of the test meals given in each week will be partially randomized. Thus, if test meals A, B or C will be given throughout 1 week between weeks 1 and 3, test meals D, E and R will be given between weeks 6 and 8. Meals containing iron with the same molecular weight (58 Fe, 57Fe and 54Fe) have to be administered at least 16 days apart from each other, which is the only restriction for randomization. The participants are not allowed to eat after 8 PM and to drink after 12 AM on the day before each study visit, between the meals and for three hours after they finished their second meal, unless they are given snacks by the investigators and are explicitly allowed to eat those. Each meal administration will take approximately 25 minutes. This procedure will be followed for six weeks, with a two weeks break between weeks 3 and 6 (no dietary restrictions within the break-period).
The test meals will be based on 50 g regular unfortified rice and 0.5 g extruded fortified rice (dry weight). The meals will be administered with one of two traditional sauces, with a low (sauce A) or moderate (sauce B) phytic acid (PA) content. Sauce A will be based on tomatoes and onions, sauce B will be based on cowpeas. The rice meals will be prepared individually for each subject, the sauce will be prepared in bulk before the study start. All meals will be served with 250 ml water. The test meals are designed to match ~2/3 of the average dietary requirements in that age-group. In case the rice meals do not provide enough energy (~700 - 900 kcal), the investigators will administer a standardized snack to be consumed during the fasting periods.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Iron fortified rice | Experimental | Other: Ferric Pyrophosphate and Zinc Oxide, Other: Ferric Pyrophosphate and Zinc Sulphate, Other: Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate, Other: Ferric Pyrophosphate, ZnSO4, CA/TSC, Other: Ferric Pyrophosphate, ZnO, CA, EDTA, Other: Ferrous SulphateAdministration of iron fortified rice to all subjects; subjects will act as their own controls and each subject will receive all foreseen treatments/interventions. |
Who may qualify
- Ages
- 5 to 9 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Iron deficient and/or anemic as per definition;
- Read and signed informed consent form by the caregiver (or has been read out to the caregiver in case of illiteracy);
- Absence of any metabolic-, gastrointestinal or chronic diseases.
Key exclusion criteria (6 listed)
- Severe underweight (Z-score weight-for-age <-3);
- Severe wasting (Z-score weight-for-height<-3);
- Chronic or acute illness or other conditions that in the opinion of the Principle Investigator (PI) or co-researchers would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol;
- Participants taking part in other studies requiring the drawing of blood;
- Participants who will not be able to comply with the protocol (e.g. plan to move, planned absence, etc.);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ferric Pyrophosphate and Zinc OxideExtruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO) and micronutrients | Other | Iron fortified rice |
| Ferric Pyrophosphate and Zinc SulphateExtruded rice fortified with Ferric Pyrophosphate, Zinc Sulphate (ZnSO4) and micronutrients | Other | Iron fortified rice |
| Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium CitrateExtruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO), Citric Acid (CA) and Trisodium Citrate (TSC) and micronutrients | Other | Iron fortified rice |
| Ferric Pyrophosphate, ZnSO4, CA/TSCExtruded rice fortified with Ferric Pyrophosphate, ZnSO4, CA/TSC and micronutrients | Other | Iron fortified rice |
| Ferric Pyrophosphate, ZnO, CA, EDTAExtruded rice fortified with Ferric Pyrophosphate, ZnO, CA, EDTA and micronutrients | Other | Iron fortified rice |
| Ferrous SulphateExtruded rice fortified with micronutrients, Ferrous Sulphate solution will be added at consumption | Other | Iron fortified rice |
Primary outcome
Fractional iron absorption
Time frame: baseline, 6 weeks, 11 weeks
Change from baseline in the isotopic ratio of iron in blood at week 6 and 11after the administration of test meal including iron isotopes.
6 secondary outcomes
Hemoglobin
Time frame: Baseline, Week 6, Week 11
Plasma Ferritin
Time frame: Baseline, Week 6, Week 11
C-reactive protein
Time frame: Baseline, Week 6, Week 11
Zinc protoporphyrin measurement as zinc to heme ratio
Time frame: Baseline, Week 6, Week 11
Soluble Transferrin receptor in mg/l
Time frame: Baseline, Week 6, Week 11
Alpha amino glycoprotein in mg/l
Time frame: Baseline, Week 6, Week 11
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Dec 2016.
- Individual participant dataSharing planned: No
Related trials for Iron Deficiency and/or Anemia
RecruitingPhase 3
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
Iron Deficiency, Anaemia in Children
RecruitingPhase 3
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
Peritoneal Dialysis, Anaemia
Recruiting
Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
Celiac Disease in Children, Anemia
Not yet recruitingPhase 4
The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes
Not yet recruitingPhase 4
The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor
Anemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michael B Zimmermann, Prof. Dr. principal investigator
Swiss FIT
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate in people with Iron Deficiency and/or Anemia, run by Swiss Federal Institute of Technology at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Ghana, Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fractional iron absorption (time frame: baseline, 6 weeks, 11 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2016.